CHD7 and CHARGE syndrome: With 90–94% of individuals diagnosed with CHARGE syndrome exhibiting cochleovestibular dysfunctions and/or malformations [13], and CHD7 mutations being responsible for the majority of cases, a multigene panel including CHD7 appears justifiable in patients presenting with unilateral hearing loss or vestibular dysfunction and typical anomalies on MRI.